Bioptik Technology, Inc. – Company Profile Company Overview Founded in 1999 and headquartered in the Hsinchu Science Park, Bioptik Technology, Inc. is a publicly traded company in Taiwan (TPEx: 4161). With over two decades of expertise, the company has established itself as a leading international manufacturer in medical diagnostics and health supplements. R&D Highlights & Innovations Bioptik possesses formidable R&D capabilities, consistently pushing the boundaries of medical technology: Pioneering Diagnostics: The company developed the world’s first "4-in-1" multi-function monitoring system (Glucose, Uric Acid, Cholesterol, and Hemoglobin) and has recently introduced an advanced "7-in-1" system. Patented Biotechnology: It holds a unique patent for extracting "Natural Astaxanthin" from apple snails, integrating biotechnology into high-end health products. Veterinary Care: Expanding its reach into animal health, Bioptik has developed specialized glucose monitoring systems for cats and dogs. Business & Sales Model The company operates through a diversified business strategy designed to provide comprehensive health solutions: Distribution & Agency: Active engagement in the distribution and representation of professional medical devices. OEM/ODM Services: Providing expert contract manufacturing (OEM/ODM) for health supplements and beauty care products. One-Stop Solutions: Bioptik has established professional product verification and contract testing platforms, offering clients a seamless transition from research to market-ready products. Domestic & Global Presence Global Reach: Bioptik’s products are exported to over 70 countries, with a strong market presence across Europe, Central and South America, and Southeast Asia. Manufacturing Excellence: The company operates three major facilities in Taiwan: Zhunan, Hsinchu Science Park (Bamboo Tech), and Tainan. Notably, the Tainan Xinshi plant is TFDA GMP certified and serves as a primary hub for production capacity expansion and advanced R&D.

Acureal